SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BAUSCH + LOMB CORP'S US SHARES FALL 3.9% IN LATE TRADE AFTER PHASE 2 STUDY RESULTS OF POST-SURGICAL OCULAR PAIN TREATMENT

BAUSCH + LOMB CORP'S US SHARES FALL 3.9% IN LATE TRADE AFTER PHASE 2 STUDY RESULTS OF POST-SURGICAL

Related stories